Gabor Peley - Publications

Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 29, 2016

Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial

Journal: Orvosi hetilap

Published: December 03, 2013

Treatment of recurrent breast cancer following breast conserving surgery.

Journal: The breast journal

Published: June 08, 2013

Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?

Journal: Clinical breast cancer

Published: September 17, 2012

Nipple adenoma arising in a supernumerary mammary gland: a case report.

Journal: Tumori

Published: February 11, 2012

Breast care nurse. A new specialist in the multidisciplinary care of breast cancer patients

Journal: Magyar onkologia

Published: November 30, 2011

Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature

Journal: Orvosi hetilap

Published: December 15, 2006

The role of sentinel lymph node biopsy in breast cancer non-invading-duct

Journal: Magyar sebeszet

Published: August 30, 2006

Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature

Journal: Orvosi hetilap

Published: March 07, 2006

The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer

Journal: Magyar onkologia

Published: December 19, 2005

Relationship between sentinel lymph node status and regression of primary malignant melanoma.

Journal: Melanoma research

Published: November 30, 2005

Administration of clexane 4000 U/0.4 ml (40 mg) for preventing venous thromboembolic complications in patients undergoing surgery for malignant tumors. A follow-up study

Journal: Magyar sebeszet

Published: September 20, 2005